Clinical Trial Update: Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib [NA]

View source ↗

Summary

Duke University is conducting a clinical trial to evaluate patient navigation for patients with HER2-positive metastatic breast cancer treated with tucatinib; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tukysa (tucatinib)

Snippet

Sponsor: Duke University | Conditions: HER2+ Metastatic Breast Cancer (MBC) | NA | Status: NOT_YET_RECRUITING